Old Web
English
Sign In
Acemap
>
Paper
>
PCN67 Estimating Cost-Effectiveness of Pembrolizumab in Advanced Esophageal Cancer Based on the Keynote-181 Trial
PCN67 Estimating Cost-Effectiveness of Pembrolizumab in Advanced Esophageal Cancer Based on the Keynote-181 Trial
2021
J. Silvers
J. Carlson
Keywords:
Internal medicine
cost effectiveness
Oncology
Pembrolizumab
Medicine
advanced esophageal cancer
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]